All Programs
Popular
- NEW EPISODEMinuteCE®
Defining the Standard of Care and Optimal Sequencing in BRAF-Mutant mCRC: Second Line and Beyond
1.00 program credit
Fortunato Ciardiello, MD, PhD
Jenny Seligmann, MBChB, PhD
- NEW EPISODEMinuteCE®
From Guidelines to Practice: First-Line Treatment Choices in mCRC
1.00 program creditFortunato Ciardiello, MD, PhD
Jenny Seligmann, MBChB, PhD
Elizabeth R. Plimack, MD, MS, FASCO
Shilpa Gupta, MD
- Clinician's Roundtable
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Brian P. McDonough, MD, FAAFP
Guy Young, MD
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
- Project Oncology®
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Shaji K. Kumar, MD
Elizabeth R. Plimack, MD, MS, FASCO
Lillibeth Velasco, MSN, RN
Elizabeth R. Plimack, MD, MS, FASCO
Lillibeth Velasco, MSN, RN
- Project Oncology®
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Charles Turck, PharmD, BCPS, BCCCP
Prithviraj Bose, MD
Charles Turck, PharmD, BCPS, BCCCP
Prithviraj Bose, MD
Tanya Dorff, MD
Jens Hillengass, MD, PhD
Neal Shore, MD
Scott Dehm, PhD
